v3.26.3
SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
12 Months Ended
Jul. 31, 2026
USD ($)
Segment
Jul. 31, 2025
USD ($)
Cash and cash equivalents held with non-banking financial institution $ 8,600,000 $ 9,200,000
Number of reportable segment | Segment 1  
Individual Counterparty [Member]    
Property and equipment, net $ 2,500  
BC Therapeutics Inc [Member]    
Investment equity method percentage 71.10%